Chronic kidney disease predicts poor prognosis in patients with stable premature coronary artery disease
Related Experiment Video
Updated: May 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Zhen Ding1, Xing Wang, Zhong Chen
1Department of Cardiology, Affiliated Zhongda Hospital and School of Medicine, Southeast University, NO.87 Dingjiaqiao, Nanjing 210009, PR China.
Insights
Chronic kidney disease (CKD) is prevalent in Chinese patients with premature coronary artery disease (CAD). CKD is linked to more risk factors and worse two-year cardiac outcomes.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- Premature coronary artery disease (CAD) affects younger individuals and its association with chronic kidney disease (CKD) requires further investigation.
- Understanding the prevalence and prognostic implications of CKD in stable, premature CAD patients is crucial for risk stratification and management.
Purpose of the Study:
- To determine the prevalence of CKD in a Chinese population with stable, premature CAD.
- To investigate the association between CKD and mid-term prognosis, specifically major adverse cardiac events (MACEs), in these patients.
Main Methods:
- A cohort of 512 patients with stable, premature CAD in Jiangsu Province, China, were enrolled.
- Chronic kidney disease (CKD) was identified using estimated glomerular filtration rate (eGFR).
- Patients were followed for two years to record and analyze major adverse cardiac events (MACEs).
Main Results:
- CKD was diagnosed in 35.74% of the patients.
- CKD was associated with increased prevalence of type 2 diabetes mellitus, multi-vessel disease, higher fasting blood sugar, and lower left ventricular ejection fraction.
- Patients with CKD experienced significantly higher composite MACEs at two-year follow-up (45.35% vs. 30.72%, P=0.001).
- A decreased eGFR correlated with an increased incidence of MACEs.
- Multivariate analysis identified CKD and multi-vessel disease as independent risk factors for MACEs.
Conclusions:
- Stable, premature CAD patients with CKD in China present with a higher burden of cardiovascular risk factors.
- CKD is independently associated with worse two-year cardiac outcomes in this population.
- Early identification and management of CKD are critical for improving prognosis in patients with premature CAD.
Objective:
This study was performed to determine the prevalence of chronic kidney disease (CKD) as well as its association with mid-term prognosis in patients with stable premature coronary artery disease (CAD) in a Chinese population.
Methods:
Five hundred and twelve patients from Jiangsu Province, China with stable, premature CAD were enrolled using an estimated glomerular filtration rate (eGFR) to determine the presence of CKD. The patients were then monitored over a two-year follow up during which major adverse cardiac events (MACEs) were recorded and analyzed.
Results:
One hundred and eighty-three patients (35.74%) were determined to have CKD. Having CKD was associated with a higher ratio of type 2 diabetes mellitus, multi-vessel disease, higher levels of fasting blood sugar and lower levels of left ventricular ejection fraction (all P<0.05). Patients with CKD had significantly higher incidences of composite MACEs than the non-CKD group at the end of the two- (45.35% vs 30.72%, P=0.001) but not one-year follow up (30.64% vs 25.32%, P=0.209). Furthermore, as eGFR decreased, more MACEs occurred (all P<0.05). Multivariate analysis confirmed that both CKD (P<0.001) and multi-vessel disease (P<0.001) are independent risk factors for MACEs.
Conclusion:
Chinese patients diagnosed with stable, premature CAD and CKD have more risk factors and worse two-year outcomes than those with only CAD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Coronary Artery Disease I: Introduction

